title: Health care consequences of black-box warnings for antidepressants in the United States and Canada.
authors.affiliation: Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston, Texas Medical Center, 1441, Moursund Street, Houston, TX 77030-3407, USA.
authors.forename: Saurabh
authors.initials: S
authors.lastname: Nagar
authors.forename: Sandhya
authors.initials: S
authors.lastname: Mehta
authors.forename: Vinod
authors.initials: V
authors.lastname: Bhatara
authors.forename: Rajender
authors.initials: R
authors.lastname: Aparasu
mesh_terms: D000293:Adolescent; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002170:Canada; D002648:Child; D004348:Drug Labeling; D006801:Humans; D007880:Legislation, Drug; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D055815:Young Adult
chemical_list: D000928:Antidepressive Agents; D017367:Selective Serotonin Reuptake Inhibitors